Baird Medical Sponsored MGH Thyroid and Parathyroid Surgery Course

New York, NY, November 15-16, 2024 — Baird Medical (NASDAQ: BDMD), a recognized leader in minimally invasive microwave ablation (MWA) technology, proudly sponsored the Surgery of the Thyroid and Parathyroid Glands Course hosted by Massachusetts General Hospital (MGH), a Harvard Medical School teaching hospital. This prestigious event, held in Boston, MA, convened top experts to share insights on advancements in thyroid and parathyroid surgery, including the latest updates in ablative technologies and evolving clinical guidelines.

A major focus of the event was a panel discussion on thermal ablation technologies, featuring a presentation by Dr. Shuhang Xu. Dr. Xu highlighted MWA's potential as an effective treatment for thyroid nodules and cancer, emphasizing its minimally invasive nature, efficiency, and precision in ablation, showcasing its increasing role in modern thyroid care.

The course also offered valuable updates on the upcoming American Thyroid Association (ATA) guidelines, innovations in advanced thyroid cancer treatment, and a variety of surgical advancements shaping the field of endocrine surgery.

Through its sponsorship, Baird Medical underscores its commitment to fostering education and collaboration within the medical community. As a trailblazer in thermal ablation technology, Baird Medical continues to support healthcare professionals with innovative and effective solutions for thyroid and parathyroid care.